Lucira Health, Inc.
LHDX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $43 | $74 | $149 | $336 |
| - Cash | $40 | $75 | $121 | $106 |
| + Debt | $48 | $48 | $31 | $3 |
| Enterprise Value | $51 | $48 | $60 | $233 |
| Revenue | $34 | $26 | $90 | $61 |
| % Growth | 31.5% | -71.1% | 48% | – |
| Gross Profit | -$100 | $8 | $40 | $13 |
| % Margin | -289.5% | 30.6% | 44.1% | 20.7% |
| EBITDA | -$124 | -$19 | $14 | -$7 |
| % Margin | -361% | -74.3% | 15.4% | -10.7% |
| Net Income | -$127 | -$22 | $13 | -$8 |
| % Margin | -368.9% | -82.9% | 14.5% | -12.3% |
| EPS Diluted | -3.15 | -0.54 | 0.31 | -0.19 |
| % Growth | -483.3% | -274.2% | 263.2% | – |
| Operating Cash Flow | -$28 | -$39 | -$5 | -$10 |
| Capital Expenditures | -$7 | -$6 | -$8 | -$5 |
| Free Cash Flow | -$35 | -$45 | -$13 | -$15 |